Physicochemical Characteristics, Cytotoxicity, and Antioxidant Activity of Three Lipid Nanoparticulate Formulations of Alpha-lipoic Acid

Abstract

Abstract. Exogenously supplied alpha-lipoic acid (LA) has proven to be effective as an antioxidant. In an effort to develop a water-soluble formulation for topical administration, LA was formulated in the form of solid lipid nanoparticles (SLN), nanostructure lipid carriers (NLC), and nanoemulsion (NE) and characterized in terms of physical and biological properties. Mean particle size of 113, 110, and 121 nm were obtained for NE, NLC, and SLN, respectively, with narrow size distribution. Zeta potential was approximately in the range of −25 to −40 mV. Disc and spherical structures of nanoparticles were observed by cryo-scanning electron microscopy. Entrapment efficiency of LA in three formulations was found to be more than 70%. After 120 days of storage at 25°C, physical stability of all formulations remained unchanged whereas the entrapment efficiency of SLN and NLC could be maintained, suggesting relative long-term stability. Prolonged release of LA formulation following the Higuchi model was found where a faster release was observed from NE compared with that of SLN and NLC. More than 80% of cell survivals were found up to 1 μM of LA concentrations. Antioxidant activity analysis demonstrated that all LA-loaded formulations expressed antioxidant activity at a similar magnitude as pure LA. These results suggest that chosen compositions of lipid nanoparticles play an important role on drug loading, stability, and biological activity of nanoparticles. Both SLN and NLC demonstrated their potential as alternative carriers for aqueous topical administration of LA.

Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come

“…NLCs can be produced by several methods, most of which are adopted from polymeric nanoparticle preparations. These methods include high-pressure homogenization (Stecova et al, 2007;Huang et al, 2008;Ruktanonchai et al, 2009); microemulsion (Doktorovova et al, 2010;Souza et al, 2011); phase inversion (Souto et al, 2007); emulsification by sonication (Das and Chaudhury, 2011); emulsification-solvent-evaporation (ESE) (Lin et al, 2010); solvent diffusion and solvent injection/solvent displacement (Schubert and MullerGoymann, 2003); and the membrane contactor method (Charcosset et al, 2005). However, the most preferred method of NLC preparation is high-pressure homogenization (Iqbal et al, 2012).…”

Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications

“…29 The stability of chemical labile hydrophobic antioxidants like retinol, Coenzyme Q10, alpha-lipoic acid, beta-carotene, and alpha-tocopherol could be enhanced when incorporating them into lipid nanoparticles. [30][31][32] Thus, the encapsulation of RSV into a lipid nanosystem might also be helpful in improving stability, whilst performing a protective effect as sufficiently as the RSV molecule itself.…”

Alpha-lipoic acid-loaded nanostructured lipid carrier: sustained release and biocompatibility to HaCaT cellsin vitro

“…To adequately utilize ALA, shortcomings associated with its sparingly solubility, photodegradation (Matsugo et al, 2011), lability and objectionable sulfur smell of ALA have to be operated before it could be used as an alternative physiologically functional active substance (Kofuji et al, 2009;Ruktanonchai et al, 2009;Moyano & Segall, 2011). Furthermore, the degradation of ALA is associated with a sulfide-smell and an irritating odour in consequence of the sulphur it contains (Kofuji et al, 2008(Kofuji et al, , 2009Takahashi et al, 2011).…”